Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Efficacy Study of MM-093 in Rheumatoid Arthritis Patients on Methotrexate (MTX)

This study has been completed.
Sponsor:
Information provided by:
Merrimack Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00105976
First received: March 18, 2005
Last updated: July 10, 2008
Last verified: July 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given